Certara Inc’s recently made public that its Officer SMITH PATRICK F acquired Company’s shares for reported $0.2 million on Apr 02 ’25. In the deal valued at $9.73 per share,20,142 shares were bought.
Then, SMITH PATRICK F sold 5,409 shares, generating $59,661 in total proceeds. Upon selling the shares at $11.03, the PRESIDENT, DRUG DEV SOLUTIONS now owns 50,091 shares.
Before that, SMITH PATRICK F bought 5,409 shares. Certara Inc shares valued at $59,661 were divested by the Officer at a price of $11.03 per share.
TD Cowen initiated its Certara Inc [CERT] rating to a Buy in a research note published on February 27, 2025; the price target was $16. A number of analysts have revised their coverage, including UBS’s analysts, who increased its forecast for the stock in late September from “a Neutral” to “a Buy”. KeyBanc Capital Markets also remained covering CERT and has increased its forecast on April 10, 2024 with a “an Overweight” recommendation from previously “Sector weight” rating. JMP Securities started covering the stock on April 04, 2024. It rated CERT as “a Mkt perform”.
Price Performance Review of CERT
On Monday, Certara Inc [NASDAQ:CERT] saw its stock fall -1.62% to $12.78. Over the last five days, the stock has lost -6.92%. Certara Inc shares have risen nearly 20.00% since the year began. Nevertheless, the stocks have fallen -26.13% over the past one year. While a 52-week high of $17.94 was reached on 02/14/25, a 52-week low of $8.64 was recorded on 04/09/25. SMA at 50 days reached $11.79, while 200 days put it at $11.96.
Levels Of Support And Resistance For CERT Stock
The 24-hour chart illustrates a support level at 12.61, which if violated will result in even more drops to 12.45. On the upside, there is a resistance level at 13.00. A further resistance level may holdings at 13.23. The Relative Strength Index (RSI) on the 14-day chart is 50.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.94%. Stochastics %K at 19.58% indicates the stock is a buying.
The most recent change occurred on February 26, 2024 when Leerink Partners began covering the stock and recommended ‘”a Market perform”‘ rating along with a $19 price target.
